指南与共识血管炎

泛美风湿病学协会联盟关于ANCA相关性血管炎治疗的指南

Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis.
指南 / 共识 · Lancet Rheumatol · 2023-07-06

泛美风湿病学协会联盟针对拉丁美洲ANCA相关性血管炎治疗差异大、环磷酰胺和长期糖皮质激素减量方案常用而循证替代方案可及性受限的现状,采用PICO格式提出问题,按GRADE方法进行系统文献综述,由血管炎专家投票(要求至少70%同意)形成21条推荐和2条专家意见声明,涵盖糖皮质激素、非糖皮质激素免疫抑制剂和血浆置换的使用。

要点

  • 该指南由泛美风湿病学协会联盟制定,针对拉丁美洲社会经济特点,采用GRADE方法系统综述证据,经专家投票(至少70%同意)形成21条推荐和2条专家意见声明。
  • 推荐内容涵盖糖皮质激素、非糖皮质激素免疫抑制剂和血浆置换在ANCA相关性血管炎治疗中的使用。
  • 拉丁美洲ANCA相关性血管炎最常用治疗为环磷酰胺和长期糖皮质激素减量方案,但近30年随机对照试验已发展出多种循证替代方案。

核心结论

  • 该指南考虑了当前证据和区域社会经济特征,形成了21条推荐和2条专家意见声明,用于ANCA相关性血管炎的治疗。

研究设计与样本

  • 泛美风湿病学协会联盟召集当地血管炎专家组,采用PICO格式提出临床相关问题,并按GRADE方法由方法学团队进行系统文献综述。
  • 专家组对每个PICO问题进行投票并提出推荐,推荐需获得投票成员至少70%的同意。

主要发现

  • 拉丁美洲ANCA相关性血管炎治疗存在相当大的差异,最常用的治疗为环磷酰胺和长期糖皮质激素减量方案。
  • 过去30年的随机对照试验已为这些患者开发出多种循证治疗替代方案。
  • 拉丁美洲面临影响医疗可及性的社会经济挑战,已证实有效但昂贵的药物使用常受限。

关键数值与推荐

  • 共形成21条推荐和2条专家意见声明,涵盖糖皮质激素、非糖皮质激素免疫抑制剂和血浆置换的使用。
  • 推荐需获得投票成员至少70%的同意。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Considerable variability exists in the way health-care providers treat patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Latin America. The most frequently used treatments for ANCA-associated vasculitis are cyclophosphamide and prolonged glucocorticoid tapers; however, randomised controlled trials conducted over the past 30 years have led to the development of several evidence-based treatment alternatives for these patients. Latin America faces socioeconomic challenges that affect access to care, and the use of certain costly medications with proven efficacy ANCA-associated vasculitis is often restricted. For these reasons, the Pan American League of Associations for Rheumatology developed the first ANCA-associated vasculitis treatment guidelines tailored for Latin America. A panel of local vasculitis experts generated clinically meaningful questions related to the treatment of ANCA-associated vasculitis using the Population, Intervention, Comparator, and Outcome (PICO) format. Following the Grading of Recommendations Assessment, Development, and Evaluation methodology, a team of methodologists conducted a systematic literature review. The panel of vasculitis experts voted on each PICO question and made recommendations, which required at least 70% agreement among the voting members. 21 recommendations and two expert opinion statements for the treatment of ANCA-associated vasculitis were developed, considering the current evidence and the socioeconomic characteristics of the region. These recommendations include guidance for the use of glucocorticoids, non-glucocorticoid immunosuppressants, and plasma exchange.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Magri SJ, Ugarte-Gil MF, Brance ML, et al. Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis. Lancet Rheumatol. 2023. PMID: 38251580. doi:10.1016/S2665-9913(23)00128-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。